| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000008894 |
| Receipt No. | R000010434 |
| Official scientific title of the study | Japan multicenter cohort study to FIND predictors of common palliative treatments: J-FIND |
| Date of disclosure of the study information | 2012/09/11 |
| Last modified on | 2016/04/11 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Japan multicenter cohort study to FIND predictors of common palliative treatments: J-FIND | |
| Title of the study (Brief title) | J-FIND2 | |
| Region |
|
|
| Condition | |||
| Condition | cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clary the predictors of effictivenss of steroids for refractory dyspnea |
| Basic objectives2 | Others |
| Basic objectives -Others | predictors of effictivenss of steroids for refractory dyspnea |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Numetric Rating Scale of dyspnea |
| Key secondary outcomes | STAS for despnea |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1 Adult
2 Advamced cancer 3 Steroid therapy for dyspnea 4 Receiving specialized palliative care services 5 NRS of dyspnea of 3 or more |
|||
| Key exclusion criteria | 1 Cognitive imparement
2 Medical contraindication for corticosteroids 3 Benign reasons for dyspnea 4 Pleural effusion |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Masanori Mori |
| Organization | Seirei Hamamatsu General Hospital |
| Division name | Pallaitive Medicine |
| Address | 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka |
| TEL | 053-474-2222 |
| Masanori.Mori@sis.seirei.or.jp | |
| Public contact | |
| Name of contact person | Masanori Mori |
| Organization | Seirei Hamamatsu General Hospital |
| Division name | Pallaitive Medicine |
| Address | 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka |
| TEL | 053-474-2222 |
| Homepage URL | |
| Masanori.Mori@sis.seirei.or.jp | |
| Sponsor | |
| Institute | Seirei Hamamatsu General Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Ministry of Health, Lavor and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 聖隷三方原病院
聖隷浜松病院 外旭川病院 聖隷三方原病院 市立札幌病院 洞爺温泉病院 KKR札幌医療センター 東札幌病院 手稲渓仁会病院 旭川医科大学病院 弘前大学医学部附属病院 岩手県立中部病院 山形大学医学部付属病院 筑波メディカルセンター病院 筑波大学附属病院 つくばセントラル病院 足利赤十字病院 国立がん研究センター東病院 亀田総合病院 帝京大学医学部 東京厚生年金病院 東芝病院 三井記念病院 聖路加国際病院 都立駒込病院 がん研究会有明病院 日本医科大学附属病院 昭和大学横浜市北部病院 横浜市立大学附属市民総合医療センター 横浜労災病院 川崎社会保険病院 川崎市立井田病院かわさき総合ケアセンター 横浜市立市民病院 新生病院 施設 佐久総合病院 新潟県立がんセンター新潟病院 村上総合病院 新潟県立加茂病院 福井県済生会病院 富山県立中央病院 静岡県立静岡がんセンター 静岡済生会総合病院 聖隷浜松病院 聖隷三方原病院 名古屋掖済会病院 総合病院 南生協病院 国立病院機構 名古屋医療センター 名古屋市立大学病院 藤田保健衛生大学 小牧市民病院 岐阜市民病院 市立伊勢総合病院 三菱京都病院 淀川キリスト教病院 ガラシア病院 国立病院機構 大阪医療センター 大阪市立総合医療センター 大阪府立成人病センター 彩都友紘会病院 近畿中央胸部疾患センター 和歌山県立医科大学附属病院 兵庫県立がんセンター 社会保険神戸中央病院 六甲病院 藤井政雄記念病院 松江市立病院 岡山済生会総合病院 広島県立広島病院 福山市民病院 施設 国立病院機構 山口宇部医療センター 松山ベテル病院 九州がんセンター 国立病院機構 都城病院 医療法人倫生会三州病院 社会医療法人友愛会 南部病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Data collection terminated |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000010434 |